Global Exosome Diagnostic And Therapeutic Market Report 2024

Exosome Diagnostic And Therapeutic Global Market Report 2024 – By Product (Instruments, Software, Reagents And Kits), By Application (Diagnostics, Therapeutic), By End User (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Exosome Diagnostic And Therapeutic Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Exosome Diagnostic And Therapeutic Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Exosome Diagnostic And Therapeutic Market Definition And Segments

Exosome diagnostics and therapeutic refer to using exosomes, tiny extracellular particles generated by cells, in diagnosis and therapy. Exosomes are used in exosome therapies as a method of targeted medication delivery for regenerative medicine.

The main products of the exosome diagnostic and therapeutic market are instruments, software, reagents, and kits. An instrument refers to equipment or instruments used to carry out activities or experiments precisely and accurately. These are used in various applications such as diagnostics and therapeutics and also by various end users such as academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

The exosome diagnostic and therapeutic market covered in this report is segmented –

1) By Product: Instruments, Software, Reagents And Kits

2) By Application: Diagnostics, Therapeutic

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.36 billion in 2023 to $0.48 billion in 2024 at a compound annual growth rate (CAGR) of 31.1%. The growth in the historic period can be attributed to biological research advancements, the emergence of precision medicine, biomedical imaging innovations, cancer research and oncology, and healthcare industry investments.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.28 billion in 2028 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to growing clinical applications, integration with digital health technologies, supportive regulatory environment, gene editing and RNA therapeutics, and expanded role in immuno-oncology. Major trends in the forecast period include exosome-based drug discovery, biomimetic exosome engineering, commercialization of exosome products, exosome-loaded therapeutic cargo, and liquid biopsy for cancer screening.

Exosome Diagnostics And Therapeutics Market Driven By Increasing Prevalence Of Chronic Diseases

The rising prevalence of chronic diseases is expected to propel the growth of the exosome diagnostic and therapeutic market going forward. Chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Diagnostic and therapeutic applications of exosomes act as possible biomarkers in cancer that provide more sensitive disease monitoring, making personalized medicine more reachable. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there will be 142.66 million people with chronic diseases worldwide by the year 2050. Therefore, the rising prevalence of chronic diseases is driving the exosome diagnostics and therapeutics market.

The Rising Geriatric Population Driving Growth In Exosome Diagnostic And Therapeutic Market

The rising geriatric population is expected to boost the growth of the exosome diagnostic and therapeutic market going forward. The term geriatric population refers to individuals who are elderly or in the later stages of life, typically aged 65 years and older. The expanding geriatric population drives the exosome diagnostics and therapeutics market, leveraging exosomes as valuable tools for diagnosing and treating age-related conditions, and meeting the demand for innovative approaches in personalized and targeted healthcare. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. Therefore, the rising geriatric population is driving the growth of the exosome diagnostic and therapeutic market.

Major companies operating in the exosome diagnostic and therapeutic market report are Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc., Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc.

Innovative Solutions In The Exosome Diagnostic And Therapeutic Market

Major companies operating in the exosome diagnostic and therapeutic market are developing innovative products, such as sample purification systems, to meet larger customer bases, increase sales, and increase revenue. A sample purification system is a set of processes and technologies designed to remove impurities and contaminants from a sample, such as DNA, RNA, proteins, or other biomolecules. For instance, in February 2023, Biological Dynamics Inc., a US-based biotechnology company, launched ExoVerita, an exosome-isolation platform for early disease surveillance and other applications. The ExoVita Pancreas assay detects particular exosomal protein indicators and has been shown to detect Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company will use this validation to test samples from the ExoLuminate registry trial (NCT05625529), which has started actively recruiting patients with high-risk PDAC to examine the test's clinical value. Patients with clinical signs such as pancreatitis or known pancreatic lesions, individuals with a genetic or familial propensity, and newly diagnosed diabetics over 50 are also eligible.

Strategic Partnership For Advancing Exosome Purification

Major companies operating in the exosome diagnostic and therapeutic market are adopting a strategic partnership approach to enhance the exosome purification process. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2023, Cytiva, a US-based biotechnology company, partnered with RoosterBio Inc., a US-based biotechnology company. The partnership is focused on enhancing the exosome purification process, which currently hinders the widespread adoption of promising gene therapies and other innovative modalities. By leveraging the strengths of both companies, this partnership aims to address a major challenge that limits the utilization of exosomes in therapeutic applications and as carriers for gene therapies and biologics. The anticipated outcome of this collaboration is the large-scale manufacturing of exosomes.

Lonza Group AG Acquired Exosome Manufacturing Facility From Codiak Biosciences Inc.

In November 2021, Lonza Group AG, a Switzerland-based contract manufacturing and development solution company, acquired an exosome manufacturing facility from Codiak BioSciences Inc. for $65 million. With this acquisition, Lonza aims to expand its offerings in exosome assay and process development, analytics, and manufacturing services and to accelerate innovations in exosome production, purification, and analytics. Codiak BioSciences Inc. is a US-based clinical-stage biopharmaceutical company that develops exosome-based therapeutics.

North America was the largest region in the exosome diagnostic and therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with an exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Exosome Diagnostic And Therapeutic Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $0.48 billion
Revenue Forecast In 2033 $1.28 billion
Growth Rate CAGR of 28.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Thermo Fisher Scientific Inc.; Lonza Group AG; Bio-Techne Corp.; Miltenyi Biotec GmBH; Malvern Instruments Inc.; BioVision Inc.; System Biosciences LLC; Evox Therapeutics Ltd.; ExCoBio Inc.; BioCat GmbH; NanoSomix Inc. ; Exosome Diagnostics Inc.; Capricor Therapeutic Inc.; Aethlon Medical Inc.; Codiak BioSciences Inc.; NX Pharmagen Inc.; Exiqon A/S; Aegle Therapeutic Corporation; AMS Biotechnology Ltd.; Cell Guidance Systems; Ciloa; Sienna Diagnostics; Sistemic Inc.; Theoria Science; Mantra Bio Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Exosome Diagnostic And Therapeutic Market Characteristics

    3. Exosome Diagnostic And Therapeutic Market Trends And Strategies

    4. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Exosome Diagnostic And Therapeutic Market Size and Growth

    5.1. Global Exosome Diagnostic And Therapeutic Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Exosome Diagnostic And Therapeutic Market Segmentation

    6.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Instruments

    Software

    Reagents And Kits

    6.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diagnostics

    Therapeutic

    6.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Academic And Research Institutes

    Pharmaceutical And Biotechnology Companies

    Hospitals And Clinics

    Other End Users

    7. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

    7.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Exosome Diagnostic And Therapeutic Market

    8.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Exosome Diagnostic And Therapeutic Market

    9.1. China Exosome Diagnostic And Therapeutic Market Overview

    9.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Exosome Diagnostic And Therapeutic Market

    10.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Exosome Diagnostic And Therapeutic Market

    11.1. Japan Exosome Diagnostic And Therapeutic Market Overview

    11.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Exosome Diagnostic And Therapeutic Market

    12.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Exosome Diagnostic And Therapeutic Market

    13.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Exosome Diagnostic And Therapeutic Market

    14.1. South Korea Exosome Diagnostic And Therapeutic Market Overview

    14.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Exosome Diagnostic And Therapeutic Market

    15.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview

    15.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Exosome Diagnostic And Therapeutic Market

    16.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Exosome Diagnostic And Therapeutic Market

    17.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Exosome Diagnostic And Therapeutic Market

    18.5. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Exosome Diagnostic And Therapeutic Market

    19.9. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Exosome Diagnostic And Therapeutic Market

    20.13. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Exosome Diagnostic And Therapeutic Market

    21.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview

    21.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Exosome Diagnostic And Therapeutic Market

    22.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Exosome Diagnostic And Therapeutic Market

    23.1. North America Exosome Diagnostic And Therapeutic Market Overview

    23.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Exosome Diagnostic And Therapeutic Market

    24.1. USA Exosome Diagnostic And Therapeutic Market Overview

    24.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Exosome Diagnostic And Therapeutic Market

    25.1. Canada Exosome Diagnostic And Therapeutic Market Overview

    25.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Exosome Diagnostic And Therapeutic Market

    26.1. South America Exosome Diagnostic And Therapeutic Market Overview

    26.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Exosome Diagnostic And Therapeutic Market

    27.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Exosome Diagnostic And Therapeutic Market

    28.1. Middle East Exosome Diagnostic And Therapeutic Market Overview

    28.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Exosome Diagnostic And Therapeutic Market

    29.1. Africa Exosome Diagnostic And Therapeutic Market Overview

    29.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

    30.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape

    30.2. Exosome Diagnostic And Therapeutic Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Lonza Group AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bio-Techne Corp.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Miltenyi Biotec GmBH

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Malvern Instruments Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

    31.1. BioVision Inc.

    31.2. System Biosciences LLC

    31.3. Evox Therapeutics Ltd.

    31.4. ExCoBio Inc.

    31.5. BioCat GmbH

    31.6. NanoSomix Inc. 

    31.7. Exosome Diagnostics Inc.

    31.8. Capricor Therapeutic Inc.

    31.9. Aethlon Medical Inc.

    31.10. Codiak BioSciences Inc.

    31.11. NX Pharmagen Inc.

    31.12. Exiqon A/S

    31.13. Aegle Therapeutic Corporation

    31.14. AMS Biotechnology Ltd.

    31.15. Cell Guidance Systems

    32. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking

    33. Global Exosome Diagnostic And Therapeutic Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

    35. Exosome Diagnostic And Therapeutic Market Future Outlook and Potential Analysis

    35.1 Exosome Diagnostic And Therapeutic Market In 2028 - Countries Offering Most New Opportunities

    35.2 Exosome Diagnostic And Therapeutic Market In 2028 - Segments Offering Most New Opportunities

    35.3 Exosome Diagnostic And Therapeutic Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Thermo Fisher Scientific Inc. Financial Performance
  • Table 75: Lonza Group AG Financial Performance
  • Table 76: Bio-Techne Corp. Financial Performance
  • Table 77: Miltenyi Biotec GmBH Financial Performance
  • Table 78: Malvern Instruments Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 75: Lonza Group AG Financial Performance
  • Figure 76: Bio-Techne Corp. Financial Performance
  • Figure 77: Miltenyi Biotec GmBH Financial Performance
  • Figure 78: Malvern Instruments Inc. Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Regenerative Medicine For Cartilage Global Market Report 2024 – By Product (Cell Based, Gene Based, Tissue Based), By End-Use (Ambulatory Surgical Centers, Hospitals And Clinics, Others), By Application (Musculoskeletal, Oncology, Dental, Wound Care, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Nerve Repair And Regenerative Global Market Report 2024 – By Product (Biomaterials, Neurostimulation And Neuromodulation Devices), By Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation And Neuromodulation Surgeries, Other Applications), By End-Users (Hospitals And Clinics, Ambulatory Surgical Centers (ASCs), Research And Academic Institutions, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Orthopedic Regenerative Surgical Products Global Market Report 2024 – By Product (Allograft, Synthetic, Cell-based, Viscosupplements), By Application (Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction), By End User (Hospitals, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Next-Generation Gynecological Cancer Diagnostics Global Market Report 2024 – By Cancer Type (Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer), By Function (Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), By Technology (Next-Generation Sequencing, qPCR And Multiplexing, Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By End User (Hospitals and Ambulatory Centers, Diagnostic Laboratories, Academic and Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Ovarian Cancer Diagnostics Global Market Report 2024 – By Product Type (Instruments, Kits, Reagents), By Diagnosis Type (Biopsy, Blood Test, Imaging, Other Diagnosis Types), By Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types), By End User (Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Precision Diagnostics Global Market Report 2024 – By Type (Genetic Tests, Esoteric tests, Other Types), By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Mass Spectrometry, Immunohistochemistry (IHC), Other Technologies), By Application (Oncology, Infectious diseases, Cardiovascular, Neurology, Genetic disorders, Other Applications), By End-User (Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical and biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Thyroid Cancer Diagnostics Global Market Report 2024 – By Technique Type (Imaging Test, Blood Test, Biopsy, Other Test Type), By Disease Type (Papillary Carcinoma, Follicular Carcinoma, Other Diseases), By End-User (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Liquid Biopsy For Cancer Diagnostics Global Market Report 2024 – By Type (Product, Services), By Sample (Blood, Urine, Saliva), By Cancer (Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers), By End-User (Hospitals, Diagnostic Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the exosome diagnostic and therapeutic market?

Exosome diagnostics and therapeutic refer to using exosomes, tiny extracellular particles generated by cells, in diagnosis and therapy. Exosomes are used in exosome therapies as a method of targeted medication delivery for regenerative medicine. For further insights on the exosome diagnostic and therapeutic market, request a sample here

How will the exosome diagnostic and therapeutic market drivers and restraints affect the exosome diagnostic and therapeutic market dynamics? What forces will shape the exosome diagnostic and therapeutic industry going forward?

The exosome diagnostic and therapeutic market major growth driver - Exosome Diagnostics And Therapeutics Market Driven By Increasing Prevalence Of Chronic Diseases. For further insights on the exosome diagnostic and therapeutic market, request a sample here

What is the forecast market size or the forecast market value of the exosome diagnostic and therapeutic market?

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.36 billion in 2023 to $0.48 billion in 2024 at a compound annual growth rate (CAGR) of 31.1%. The growth in the historic period can be attributed to biological research advancements, emergence of precision medicine, biomedical imaging innovations, cancer research and oncology, healthcare industry investments. The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $1.28 billion in 2028 at a compound annual growth rate (CAGR) of 28.1%. The growth in the forecast period can be attributed to growing clinical applications, integration with digital health technologies, supportive regulatory environment, gene editing and rna therapeutics, expanded role in immuno-oncology. Major trends in the forecast period include exosome-based drug discovery, biomimetic exosome engineering, commercialization of exosome products, exosome-loaded therapeutic cargo, liquid biopsy for cancer screening. For further insights on the exosome diagnostic and therapeutic market, request a sample here

How is the exosome diagnostic and therapeutic market segmented?

The exosome diagnostic and therapeutic market is segmented
1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End UsersFor further insights on the exosome diagnostic and therapeutic market, request a sample here

Which region has the largest share of the exosome diagnostic and therapeutic market? What are the other regions covered in the report?

North America was the largest region in the exosome diagnostic and therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the exosome diagnostic and therapeutic market, request a sample here.

Who are the major players in the exosome diagnostic and therapeutic market?

Major companies operating in the exosome diagnostic and therapeutic market report are Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Techne Corp., Miltenyi Biotec GmBH, Malvern Instruments Inc., BioVision Inc., System Biosciences LLC, Evox Therapeutics Ltd., ExCoBio Inc., BioCat GmbH, NanoSomix Inc. , Exosome Diagnostics Inc., Capricor Therapeutic Inc., Aethlon Medical Inc., Codiak BioSciences Inc., NX Pharmagen Inc., Exiqon A/S, Aegle Therapeutic Corporation, AMS Biotechnology Ltd., Cell Guidance Systems, Ciloa, Sienna Diagnostics, Sistemic Inc., Theoria Science, Mantra Bio Inc. For further insights on the exosome diagnostic and therapeutic market, request a sample here.

What are the key trends in the exosome diagnostic and therapeutic market?

Major trend in the exosome diagnostic and therapeutic market - Innovative Solutions In The Exosome Diagnostic And Therapeutic Market. For further insights on the exosome diagnostic and therapeutic market, request a sample here.

What are the major opportunities in the exosome diagnostic and therapeutic market? What are the strategies for the exosome diagnostic and therapeutic market?

For detailed insights on the major opportunities and strategies in the exosome diagnostic and therapeutic market, request a sample here.

How does the exosome diagnostic and therapeutic market relate to the overall economy and other similar markets?

For detailed insights on exosome diagnostic and therapeutic market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the exosome diagnostic and therapeutic industry?

For detailed insights on the mergers and acquisitions in the exosome diagnostic and therapeutic industry, request a sample here.

What are the key dynamics influencing the exosome diagnostic and therapeutic market growth? SWOT analysis of the exosome diagnostic and therapeutic market.

For detailed insights on the key dynamics influencing the exosome diagnostic and therapeutic market growth and SWOT analysis of the exosome diagnostic and therapeutic industry, request a sample here.